- Home
- CARG vs VKTX Comparison
CARG vs VKTX Comparison
Compare CARG & VKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CARG
- VKTX
- Stock Information
- Founded
- CARG 2005
- VKTX 2012
- Country
- CARG United States
- VKTX United States
- Employees
- CARG N/A
- VKTX N/A
- Industry
- CARG EDP Services
- VKTX Biotechnology: Pharmaceutical Preparations
- Sector
- CARG Technology
- VKTX Health Care
- Exchange
- CARG Nasdaq
- VKTX Nasdaq
- Market Cap
- CARG 3.4B
- VKTX 3.4B
- IPO Year
- CARG 2017
- VKTX 2015
- Fundamental
- Price
- CARG $26.61
- VKTX $23.94
- Analyst Decision
- CARG Buy
- VKTX Strong Buy
- Analyst Count
- CARG 11
- VKTX 12
- Target Price
- CARG $37.14
- VKTX $89.75
- AVG Volume (30 Days)
- CARG 1.5M
- VKTX 4.5M
- Earning Date
- CARG 05-08-2025
- VKTX 04-23-2025
- Dividend Yield
- CARG N/A
- VKTX N/A
- EPS Growth
- CARG 2.19
- VKTX N/A
- EPS
- CARG 0.20
- VKTX N/A
- Revenue
- CARG $894,384,000.00
- VKTX N/A
- Revenue This Year
- CARG $8.21
- VKTX N/A
- Revenue Next Year
- CARG $7.98
- VKTX N/A
- P/E Ratio
- CARG $134.83
- VKTX N/A
- Revenue Growth
- CARG N/A
- VKTX N/A
- 52 Week Low
- CARG $21.18
- VKTX $18.92
- 52 Week High
- CARG $41.33
- VKTX $81.86
- Technical
- Relative Strength Index (RSI)
- CARG 38.00
- VKTX 46.06
- Support Level
- CARG $26.33
- VKTX $18.92
- Resistance Level
- CARG $27.60
- VKTX $27.09
- Average True Range (ATR)
- CARG 1.51
- VKTX 2.31
- MACD
- CARG 0.11
- VKTX 0.26
- Stochastic Oscillator
- CARG 39.32
- VKTX 61.44
About CARG CarGurus Inc.
CarGurus Inc is a company that acts as an online automotive marketplace connecting buyers and sellers of new and used cars. The company provides three types of marketplace Listing products, Restricted Listings, and Enhanced or Featured Listings, through which it offers real-time and historical data analyzing the connections and pricing analysis. The listing platforms offer auto manufacturers and others to buy advertising on the company's site and target consumers based on the make, model, and zip code of the cars. The company operates through two segments, namely U.S. Marketplace and Digital Wholesale. It generates maximum revenue from the U.S. Marketplace segment. Geographically, the company derives its key revenue from the United States and the rest from international markets.
About VKTX Viking Therapeutics Inc.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.